In the BioHarmony Drug Report Database

"Preview" Icon

Nalbuphine

Nalbuphine, Nubain (nalbuphine) is a small molecule pharmaceutical. Nalbuphine was first approved as Nalbuphine on 1982-01-01. It is used to treat postoperative pain in the USA. The pharmaceutical is active against kappa-type opioid receptor, delta-type opioid receptor, and mu-type opioid receptor. In addition, it is known to target kappa-type opioid receptor.

 

Trade Name

 

Nalbuphine, Nubain
 

Common Name

 

nalbuphine
 

ChEMBL ID

 

CHEMBL895
 

Indication

 

postoperative pain
 

Drug Class

 

Narcotic agonists/antagonists (normorphine type)

Image (chem structure or protein)

Nalbuphine structure rendering